期刊
CLINICAL MICROBIOLOGY AND INFECTION
卷 19, 期 4, 页码 331-337出版社
ELSEVIER SCI LTD
DOI: 10.1111/1469-0691.12170
关键词
Atherosclerosis; atherothrombosis; intestinal microbiota; non-alcoholic fatty liver disease; obesity; thrombosis
资金
- TIFN [GH-003]
- ZonMW-VENI [016.096.044]
- Academy of Finland
- Netherlands Organization for Scientific Research
Whereas the association between intestinal microorganisms and health has been widely accepted in the area of infectious disease, recent advances have now implied a role for the intestinal microbiota in human energy balance. In fact, numerous studies support an intricate relationship between the intestinal microbiota and obesity, as well as subsequent insulin resistance and non-alcoholic fatty liver disease. Intestinal microorganisms also seem to be involved in haemostatic tone and atherogenesis. However, as most of the findings stem from observational data, intervention studies in humans using interventions selectively aimed at altering the composition and activity of the intestinal microbiota are crucial to prove causality. If substantiated, this could open the arena for modulation of the intestinal microbiota as a future target in obesity-associated disease, both as a diagnostic test for personalized algorithms and for selective therapeutic strategies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据